Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 21, 2001
Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks
D Rey, M P Schmitt, M Partisani, et al.
Leukemia Research
|
January 1, 1984
Membrane markers, karyotypic abnormalities, ultrastructure and functional properties of lymphocytes in a case of 'D-cell' chronic lymphatic leukemia
J P Bergerat, J M Lang, S Lévy, et al.
Annals of Hematology
|
May 1, 1991
DNA amplification of HIV genome in hemophiliacs and in newborns from seropositive mothers
C de la Salle, M J Baas, D Laustriat, et al.
American Journal of Public Health
|
June 8, 1999
Characteristics of nurse-midwife patients and visits, 1991
L L Paine, J M Lang, D M Strobino, et al.
AIDS (London, England)
|
October 28, 1997
Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA
Y Mouton, S Alfandari, M Valette, et al.
Vaccine
|
January 29, 2000
Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load
D Rey, V Krantz, M Partisani, et al.
Nature Communications
|
March 22, 2021
Structural resolution of switchable states of a de novo peptide assembly
William M Dawson, Eric J M Lang, Guto G Rhys, et al.
Phytopathology
|
July 6, 2017
Detection and Characterization of Xanthomonas vasicola pv. vasculorum (Cobb 1894) comb. nov. Causing Bacterial Leaf Streak of Corn in the United States
J M Lang, E DuCharme, J Ibarra Caballero, et al.
Medecine Et Maladies Infectieuses
|
September 6, 2005
[Hepatitis A seroprevalence in HIV-infected patients]
D Rey, E Frick-Michot, M Partisani, et al.
Presse Medicale (Paris, France : 1983)
|
March 26, 2004
[Predictive factors of virological response to primary antiretroviral treatment]
J-F Faucher, B Challier, C Chirouze, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 21, 2001
Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks
D Rey, M P Schmitt, M Partisani, et al.
Leukemia Research
|
January 1, 1984
Membrane markers, karyotypic abnormalities, ultrastructure and functional properties of lymphocytes in a case of 'D-cell' chronic lymphatic leukemia
J P Bergerat, J M Lang, S Lévy, et al.
Annals of Hematology
|
May 1, 1991
DNA amplification of HIV genome in hemophiliacs and in newborns from seropositive mothers
C de la Salle, M J Baas, D Laustriat, et al.
American Journal of Public Health
|
June 8, 1999
Characteristics of nurse-midwife patients and visits, 1991
L L Paine, J M Lang, D M Strobino, et al.
AIDS (London, England)
|
October 28, 1997
Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA
Y Mouton, S Alfandari, M Valette, et al.
Vaccine
|
January 29, 2000
Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load
D Rey, V Krantz, M Partisani, et al.
Nature Communications
|
March 22, 2021
Structural resolution of switchable states of a de novo peptide assembly
William M Dawson, Eric J M Lang, Guto G Rhys, et al.
Phytopathology
|
July 6, 2017
Detection and Characterization of Xanthomonas vasicola pv. vasculorum (Cobb 1894) comb. nov. Causing Bacterial Leaf Streak of Corn in the United States
J M Lang, E DuCharme, J Ibarra Caballero, et al.
Medecine Et Maladies Infectieuses
|
September 6, 2005
[Hepatitis A seroprevalence in HIV-infected patients]
D Rey, E Frick-Michot, M Partisani, et al.
Presse Medicale (Paris, France : 1983)
|
March 26, 2004
[Predictive factors of virological response to primary antiretroviral treatment]
J-F Faucher, B Challier, C Chirouze, et al.
Page
of 14